| Title | Venue | Year | Impact | Source |
| 6451 | A physiotherapy governance group implemented during the COVID-19 pandemic ensures effective patient centered care within an NHS Musculoskeletal Physiotherapy department | Physiotherapy | 2022 | | CORD-19 |
| 6452 | The experience of physiotherapy and occupational therapy students of pandemic teaching and its perceived impact on placement/practice | Physiotherapy | 2022 | | CORD-19 |
| 6453 | Development of a multi-component risk assessment process for face to face consultations in an outpatient setting Keywords: COVID-19;Risk assessment;Face-to-face Purpose: The aim of developing a standardised risk assessment process was to aid physiotherapists in balancing clinical need and risk mitigation when planning care and using that information to facilitate informed shared decision with people using the service when considering virtual or face to face consultations. Methods: A multi-component risk assessment process was developed using the Chartered Society of Physiotherapy's 7 factors to consider when planning face to face consultations and NHS England guidance as the core foundation. Specific components included COVID-19 screening, clinical vulnerability, age, gender, ethnicity, smoking and alcohol intake, clinical need, red flags, consideration of virtual consultation, consideration of patient carers and vulnerable household members, risk mitigation, shared decision making and informed consent. The document was shared with a multi-professional team and members of the equality, diversity and inclusion team to ensure the process was inclusive and sensitive to our diverse staffing group. Results: The risk assessment framework was formally ratified by the Trust clinical governance group and adopted as part of the combined therapy services electronic note system and became a component of the electronic notes audit to ensure appropriate use. The process was also used by multi-profession services outside of therapies. Conclusion(s): The impact of the COVID-19 pandemic has meant services have evolved new ways of working to ensure delivery of quality patient care safely with shared decision making integral to the process. The development of the standardised risk assessment form supported clinicians and patients in making fully informed shared decisions about their care plan. Impact: The impact of this project was that patents who had a clinical need and/ or preference for face to face treatment were able to make informed decisions about their care balancing clinical need and risk in a transparent and inclusive way. Funding acknowledgements: Not funded. | Physiotherapy | 2022 | | CORD-19 |
| 6454 | The interaction between fatigue and anxiety in people post hospitalisation with COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6455 | The impact of early mobilisation in patients within the Covid-19 high dependency unit | Physiotherapy | 2022 | | CORD-19 |
| 6456 | Implementation of virtual consultations within an acute MSK Physiotherapy pediatric service, in response to the Covid-19 pandemic-Patient/parent feedback | Physiotherapy | 2022 | | CORD-19 |
| 6457 | Implementation of virtual consultations within an MSK Physiotherapy pediatric service, in response to the Covid-19 pandemic -Therapists experience/feedback | Physiotherapy | 2022 | | CORD-19 |
| 6458 | Physiotherapy staff experiences during COVID-19: A service evaluation, framework analysis and recommendations for a future physiotherapy service | Physiotherapy | 2022 | | CORD-19 |
| 6459 | Patient and staff satisfaction of physiotherapy delivered remotely during the COVID-19 pandemic: A service evaluation | Physiotherapy | 2022 | | CORD-19 |
| 6460 | Embracing digital technology in response to the COVID-19 pandemic: A patient satisfaction service evaluation | Physiotherapy | 2022 | | CORD-19 |
| 6461 | Musculoskeletal service transformation in a post-Covid world as part of the creation of a new city-wide single hospital service | Physiotherapy | 2022 | | CORD-19 |
| 6462 | A retrospective review of the use of telephone and video consultations for a musculoskeletal service during COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6463 | The experience of people with cancer maintaining their physical activity with digital service delivery during COVID-19-A service evaluation | Physiotherapy | 2022 | | CORD-19 |
| 6464 | Hybrid musculoskeletal (MSK) classes in the age of COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6465 | Neurological rehabilitation post-COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6466 | Utilising a specialist orthopedic home support team to provide rehabilitation post fracture neck of femur during the COVID pandemic | Physiotherapy | 2022 | | CORD-19 |
| 6467 | COVID-19: Physiotherapy students experience during practice placement in the UK | Physiotherapy | 2022 | | CORD-19 |
| 6468 | Supporting survivorship after critical illness: A service improvement project at a large teaching hospital | Physiotherapy | 2022 | | CORD-19 |
| 6469 | COVID-19, child inactivity and the introduction of an online exercise class | Physiotherapy | 2022 | | CORD-19 |
| 6470 | An artificial intelligence platform for movement analysis and rehabilitation: Clinical applications of stepsense to complex pain and long covid | Physiotherapy | 2022 | | CORD-19 |
| 6471 | The prevalence, location and severity of musculoskeletal pain following COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6472 | Evaluation of patient reported outcomes following pain management programmes delivered via video conferencing during the Covid-19 pandemic | Physiotherapy | 2022 | | CORD-19 |
| 6473 | Characteristics and therapy needs of COVID-19 survivors between critical care and acute hospital discharge: A single center observational cohort study | Physiotherapy | 2022 | | CORD-19 |
| 6474 | Outcomes of an exercise medicine programme for patients undergoing cancer treatment and its adaptation to a virtual model during COVID-19 | Physiotherapy | 2022 | | CORD-19 |
| 6475 | Learning through COVID-19: Using digital technology to compare undergraduate clinical placement competency data, before and during the global pandemic | Physiotherapy | 2022 | | CORD-19 |
| 6476 | Reconnect2life-Getting comfortable being uncomfortable: Using telerehabilitation to support patients with chronic pain during Covid-19 | Physiotherapy | 2022 | | CORD-19 |
| 6477 | Brachial plexus neuropathies during the COVID-19 pandemic: A retrospective case series of 15 patients in critical care | Physiotherapy | 2022 | | CORD-19 |
| 6478 | Use of an online web-resource with COVID-19 patients in the community and in hospital: An impact evaluation assessing patient experience | Physiotherapy | 2022 | | CORD-19 |
| 6479 | A dedicated virtual musculoskeletal service for patients following ICU admission with Covid-19: A service development project | Physiotherapy | 2022 | | CORD-19 |
| 6480 | Persisting symptoms in patients following hospital admission with COVID-19: An observational cohort study | Physiotherapy | 2022 | | CORD-19 |
| 6481 | A service evaluation of remote consultation mediums in a physiotherapy department during the COVID-19 pandemic | Physiotherapy | 2022 | | CORD-19 |
| 6482 | COVID-19 in patients with transfusion dependent thalassemia in Indonesia: characteristics of the disease and patients and comparison between epidemiological data for COVID-19 and thalassemia in Indonesia and Southeast Asia People living with transfusion dependent thalassemia have a high risk of getting infected by COVID-19. This can be caused both by internal factors, namely the formation of alloantibodies and autoimmune disorders, and external factors such as routine visits for blood transfusions. Chronic complications of thalassemia also render the patients more vulnerable to infectious diseases, including COVID-19. However, anecdotal data shows that thalassemia patients have less incidence of COVID-19 if compared to the general population. This study aims to find the correlation between COVID-19 in thalassemia-dependent transfusion patients in Indonesia and South-East Asia. This research used a cross-sectional design. The study was conducted at the Division of Haematology and Medical Oncology of the Cipto Mangunkusumo Hospital in Jakarta, from May 2020 to August 2021. Total sampling method was used involving all thalassemia major patients who had been infected with COVID-19 obtained directly from medical records and through the thalassemia patients’ parents foundation. In 10,397 patients with thalassemia, 67 (0.64%) people were infected by COVID-19 and two (2.9%) died. Meanwhile, the incidence of COVID-19 in the general population of Indonesia was 0.87%, more than in the thalassemia population. This means that thalassemia might provide additional protection against COVID-19 due to several mechanisms. This phenomenon is also seen in other countries with a high prevalence of thalassemia, which show less COVID-19 cases despite the pandemic. On the contrary, countries with low rates of thalassemia carriers had experienced deadly surges of the pandemic. Indonesia and other countries with a high prevalence of thalassemia have lower COVID-19 incidence than countries with a low prevalence of thalassemia. Thalassemia might provide additional protection against COVID-19. Well designed studies are needed to provide better evidence on the protective effect of thalassemia against COVID-19. | Hematol Rep | 2022 | | CORD-19 |
| 6483 | Public Service Motivation of Street- Level Bureaucrats Amidst the COVID-19 Pandemic: An Analysis of Experiences in Implementation of an at-Home Vaccination Program This article details public service motivation of emergency medical services (EMS) personnel within a local fire department in Texas, as they implemented an at-home vaccination program, amidst the COVID-19 pandemic. EMS personnel were surveyed and interviewed to learn more about their professional experiences. Using mixed methods, this work finds that EMS personnel in the local department exhibit high levels of public service motivation in both deciding to participate in the at-home vaccination program and throughout their experience in administering the vaccine to community members. This research offers insight local public servants’ motives during a time of crisis and while working in a new, innovative capacity. | N/A | 2022 | | CORD-19 |
| 6484 | COVID-19 Surges Then Crickets and the Impact on the Emergency Department Workforce | Ann Emerg Med | 2022 | | CORD-19 |
| 6485 | COVID-19 et maladies bulleuses auto-immunes en 2022 La pandémie provoquée par la COVID-19 évolue quotidiennement, obligeant les autorités sanitaires et médecins à s’adapter. Les patients atteints de maladies bulleuses auto-immunes (MBAI), très souvent âgés ou immunodéprimés, constituent une population à très haut risque d’évolution vers une forme sévère. Ce travail de recueil sur l’impact de la COVID-19 sur les patients atteints de MBAI a permis de ressortir plusieurs messages clés : i) la prescription de rituximab est associée à un surrisque de mortalité contrairement aux immunosuppresseurs conventionnels ; ii) la prescription de rituximab doit être réservée à des patients en poussée de leur maladie, sans alternative thérapeutique ; iii) la vaccination du patient et de son entourage est, encore aujourd’hui, la meilleure arme afin de diminuer le risque d’évolution vers une forme sévère. The COVID-19 pandemic is evolving daily, forcing health authorities and physicians to continuously adapt. Patients with autoimmune bullous diseases (ABD), who are often elderly and/or immunocompromised, constitute a population at very high risk of developing a severe form. This study on the impact of COVID-19 on patients with AIBD has brought out several key messages: i) the prescription of rituximab is associated with an increased risk of mortality, contrary to conventional immunosuppressants; ii) rituximab should only be prescribed for patients in flare-up of their disease, in the absence of any therapeutic alternative; iii) vaccination of patients and their entourage is still the best solution for reducing the risk of progression to a severe form. | N/A | 2022 | | CORD-19 |
| 6486 | Florida Efforts to Address Covid-19 A Model for National Replication: 8.3.2020 | J Natl Med Assoc | 2020 | | CORD-19 |
| 6487 | 2020 National Medical Association Pediatric Section Annual Program Abstracts | J Natl Med Assoc | 2020 | | CORD-19 |
| 6488 | Impacts of the Dance PAMOJA Challenge on COVID-19 related-outcomes | J Natl Med Assoc | 2020 | | CORD-19 |
| 6489 | Webinar Review: Psychiatric Leaders impressions on Racism and Covid 19 Phenomenon | J Natl Med Assoc | 2020 | | CORD-19 |
| 6490 | 15th Annual W. Montague Cobb Symposium and Lectureship: A Celebration of the HBS/OMH Morehouse SOM Award and Vital HBCU Consortium Strategy to Tackle Covid Disparities -- "The Power Of 4" | J Natl Med Assoc | 2020 | | CORD-19 |
| 6491 | Analysis of the Effect of Introducing Stress onto Medical Practitioners in Modern American Healthcare | J Natl Med Assoc | 2020 | | CORD-19 |
| 6492 | Understanding Mortality and Morbidity Rates among Cancer patients from the Emergency Department | J Natl Med Assoc | 2020 | | CORD-19 |
| 6493 | Stock market contagion during the COVID-19 pandemic in emerging economies The purpose of this paper is to examine the connected dynamics of the affected Asian financial markets and global financial market in relation to the outbreak of the coronavirus (COVID-19) pandemic. We particularly examine the temporal dependence and connectedness of the affected markets with the global financial market by using the time-varying dependence approach in a time-frequency space under COVID-19. Our findings indicate a strong, positive dependence among the investigated markets’ due to the outbreak of COVID-19. In addition, we report an increased tendency of co-movements over the higher horizon which is documented by COVID-19. These findings are of significant interest for market participants, policymakers, and international investors. | N/A | 2022 | | CORD-19 |
| 6494 | Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis Sahu AK, Mathew R, Bhat R, et al. QJM. 2021 Aug 4;hcab212. doi: 10.1093/qjmed/hcab212. Epub ahead of print | J Emerg Med | 2022 | | CORD-19 |
| 6495 | Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. Brandon Metra, Ross Summer, Sandra Elaine Brooks, et al. Thromb Res. 2021;205:84-91 | J Emerg Med | 2022 | | CORD-19 |
| 6496 | Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Healthcare Workers Sebastian Haverall, Axel Rosell, Mia Phillipson, et al JAMA. 2021;325(19):2015-2016 | J Emerg Med | 2022 | | CORD-19 |
| 6497 | Clinical outcome of shielded patients who have been infected with COVID-19 in Barnsley Borough- June 2020 Background Severe acute respiratory syndrome – coronavirus-2 has caused a pandemic that put the life of extremely vulnerable people who are eligible for shielding from COVID-19 at a greater risk. The UK government had advised those vulnerable people to start shielding by 21st of March 2020. Methods This study is a retrospective review of 74 patients who had laboratory confirmed covid 19 disease (tested between 31/03/2020–13/05/2020) and identified by Barnsley hospital information database as eligible for shielding. The reviewed cases were evaluated for clinical outcome, reasons for shielding, demographic distribution, place of residence and history of recent hospital stay. Results 74 patients [median age 76.4 , males – 53%] were included, of which 48.6% [n = 36, median age 81.5] had died. 43 out of all 74 patients had COPD (chronic obstructive pulmonary disease) and 24 [56%] of them had died. 24 patients [32.4%] lived in care homes.19 out of all 74 patients were in-patient after 21st March for reasons other than COVID19 and diagnosed with COVID19 following discharge from hospital. Conclusion The study describes notably higher mortality from COVID19 in the shielding group, particularly in elderly patients and those with pre-existing COPD diagnosis. This group must be given priority when offering vaccination. The study has also revealed the need to adopt strict infection control measures to minimise infection transmission in care homes. Introducing a quicker way of testing on admission to hospital (e.g., point of care testing) would facilitate efficient triaging and bed allocation, which could subsequently reduce the risk of nosocomial infection. | Clin Infect Pract | 2022 | | CORD-19 |
| 6498 | COVID-19 associated pulmonary aspergillosis (CAPA) case series in NHS Greater Glasgow and Clyde (GGC) The aim of this study was to describe the patient's characteristics and clinical course of CAPA and to investigate possible association of Dexamethasone with CAPA incidence. This is a retrospective descriptive study. All adult patients in GGC NHS with laboratory proven SARS-CoV-2 infection who subsequently had Aspergillus species isolated from their respiratory samples between 01/02/20 and 31/01/21were included. A total of 24 patients fulfilled the inclusion criteria.79% of the cases were between October/2020-January/2021 coinciding with the second wave of COVID-19 and the increased use of steroids after the RECOVERY trial results. Based on the proposed screening and diagnostic algorithm for CAPA and Modified AspITU classification, 6 patients had likely/putative, and 2 patients had highly likely/probable CAPA, respectively. Based on the CAPA algorithm, for 11 patients CAPA was not excluded and 5 considered colonization. Based on Modified AspITU, 10 considered query Putative CAPA and 6 colonization. 13 patients were males. The median age was 62. 46% of patients had underlying lung disease, 20% had previous exposure to inhaled steroids, 8% to Methotrexate, 4% to each of systemic steroids and Rituximab. 79% of patients received Dexamethasone and 12.5% received Tocilizumab for COVID-19. 75% of patients were in ITU at time of first Aspergillus isolation. 67% of patients received antifungal for CAPA. CAPA remains an area of research. From our limited data, we observed an association between Dexamethasone use and incidence of CAPA. We also noticed a correlation between the number of samples with positive Aspergillus species culture from the same patient and the likelihood of CAPA diagnosis. | Clin Infect Pract | 2022 | | CORD-19 |
| 6499 | Urinary antigen testing for respiratory infection during COVID-19: The microbiologist as a diagnostic steward The use of antimicrobials in the management of community-acquired COVID-19 is commonplace but evidence for coinfection with common bacterial pathogens to justify their use is lacking. We undertook a retrospective review of all respiratory cultures, blood cultures and urinary antigen tests in COVID-19 patients looking for co-infection with Streptococcus pneumoniae and Legionella pneumophila, and specifically to judge the utility of urinary antigen testing. 2674 GSTT patients were included who hada positive RT-PCR test for SARS-CoV-2 performed at GSTT between 03-March-2020 and 31-Jan-2021 and who had at least one other microbiology sample for review. | Clin Infect Pract | 2022 | | CORD-19 |
| 6500 | Impact of COVID-19 on 2020 transplant activity and waiting lists in France✰,✰✰ The COVID-19 pandemic strongly affected organ procurement and transplantation in France, despite the intense efforts of all participants in this domain. In 2020, the identification and procurement of deceased donors fell by 12% and 21% respectively, compared with the mean of the preceding 2 years. Similarly, the number of new registrations on the national waiting list declined by 12% and the number of transplants by 24%. The 3-month cumulative incidence of death or drop out for worsening condition of patients awaiting a liver transplant was significantly greater in 2020 compared to the previous 2 years. Continuous monitoring at the national level of early post-transplant outcomes showed no deterioration for any organ in 2020. At the end of 2020, less than 1% of transplant candidates and less than 1% of graft recipients — of any organ — had died of COVID-19. | N/A | 2021 | | CORD-19 |
